• Persephone, the Real-Time Genome Browser

    Bio-IT World | Though Ceres never expected to become a software provider, the plant engineering company has found itself with a platform for viewing and exploring genetic data that it believes will vastly outperform the industry standard.

    Apr 25, 2014

  • Working Group Recommendations for Investigating Causality for Sequence Variants

    Bio-IT World | An excellent Nature Perspectives piece, published today, takes on the issues surrounding causality. The paper represents the conclusions of a working group of experts in genomic research, analysis and clinical diagnostic sequencing convened by the US National Human Genome Research Institute.

    Apr 23, 2014

  • BaseHealth Seeks New Model for Offering Patients Genetic Health Information

    Bio-IT World | This morning, Los Altos-based startup BaseHealth emerged from stealth mode to announce the launch of Genophen, a preventive medicine platform that unites clinical and genetic data to help patients track and manage their risk of developing common chronic diseases.

    Apr 22, 2014

  • Pfizer Rebuffed by AstraZeneca, Regroups

    Bloomberg | Talks between Pfizer and AstraZeneca fizzled, but the possibility foretells future big deals, analysts say.

    Apr 22, 2014

  • More Big Pharma Shakeup: Novartis, GSK Trade Assets

    REuters | Novartis and GlaxoSmithKline announced this morning that they two big pharma are trading over $20 billion worth of assets in an attempt to strengthen their best businesses

    Apr 22, 2014

  • To Speed Sequencing, Edico Genome Proposes NGS Processor

    Bio-IT World | Of sequencing bottlenecks, the most lamented is the analysis pipeline. Edico Genome is developing the DRAGEN Bio-IT Processor, the world’s first Next Generation Sequencing (NGS) bioinformatics ASIC to speed and smooth that process.

    Apr 21, 2014

  • Remarkable Twin Study Widens View of Down's Syndrome

    Bio-IT World News Brief | A large coalition of European and American researchers this week published a new gene expression study of trisomy 21, better known as Down's syndrome, using a novel cellular model of the disorder.

    Apr 18, 2014

  • As Genetics Moves to the Clinic, Pathogenic Variants Still Subject to Doubt and Debate

    Bio-IT World | Genetic diagnostics is a growing field with great promise for improving medical care—yet interpreting the results of tests is a painstaking process, and different labs can disagree on which variants contribute to disease. As open science advocates seek to collect together and curate our knowledge of disease-related genes, the reluctance of many clinical labs to share their data continues to hinder progress.

    Apr 17, 2014

  • Novartis Out of RNAi Research

    Forbes | Novartis bows out of RNAi research, the second big pharma to do so.

    Apr 15, 2014

  • Broad Claims Patent on CRISPR Technology

    Bio-IT World News Brief | The U.S. Patent and Trademark Office this morning issued the first patent to cover CRISPR-Cas9 gene editing, awarding the Broad Institute a patent for a version of the CRISPR-Cas9 system used to modify the DNA of mammalian cells.

    Apr 15, 2014

  • In Last Sprint to Product Launch, Edico Genome Hints at Massively Accelerated Informatics

    U-T San Diego | San Diego-based Edico Genome is working on a chip-based system, the Dragen Wavefront Processor, to perform first-line analysis of genetic information in a fraction of the time required by the fastest current methods.

    Apr 14, 2014

  • Bio-Rad Picks Up GnuBIO, Droplet-Based Sequencing

    Bio-IT World News Brief | Bio-Rad has acquired GnuBIO, a next-generation droplet-based DNA sequencing technology. GnuBIO's DNA sequencing solution integrates the entire sample preparation workflow on a chip.

    Apr 11, 2014

  • Duke's Plans for the Soon-to-be Defunct Institute for Genome Sciences

    Duke Chronicle | Duke's plans for the Institute for Genome Sciences & Policy were made public in late March--a formal dismantling July 1.

    Apr 10, 2014

  • FDA Grants Breakthrough Status to Gene Therapy for First Time

    Bio-IT World News Brief | Celladon today became the first company to receive breakthrough status for a gene therapy treatment in development. The treatment, MYDICAR, is intended to reduce the risk of heart failure in patients with a deficiency of the enzyme SERCA2a.

    Apr 10, 2014

  • AWS, Google, Microsoft Chop Cloud Prices

    Computerworld | A string of price cuts from Google, Amazon Web Services, and Microsoft has further driven down the price of cloud computing.

    Apr 10, 2014

  • Aspera on Life with IBM, and Bio-IT World Expo Plans

    Bio-IT World | A few months after Aspera's acquisition by IBM, Bio-IT World caught up with Aspera CEO Michelle Munson, a Bio-IT World Conference & Expo speaker and exhibitor, to hear the latest on life at Big Blue and what’s new in Aspera’s pipeline. 

    Apr 10, 2014

  • India's Open Source Experiment Short on Funds, Talent

    Bio-IT World Roundup | More challenges for India's Open Source Drug Development project. The Indian Ministry of Science and Technology reportedly did not clear the cabinet note meant to extend funding for the Open Source Drug Discovery project and the project is facing a serious talent shortage.

    Apr 9, 2014

  • Mouse Models, Wayward Trials, and New Guidelines

    Bio-IT World Roundup | A March 26 Nature comment is getting press today. Steve Perrin, chief scientific officer at the ALS Therapy Development Institute in Cambridge, Mass., is frustrated with the mouse models driving ALS research.

    Apr 8, 2014

  • New Life for Cancer Immunotherapy

    Technology Review | Data presented at the American Association of Cancer Researchers (AACR) event over the weekend heralded the revival of cancer immunotherapy.

    Apr 7, 2014

  • Annual IT Worker Salary Survey Released

    Computerworld | Computerworld released its 2014 Salary Survey for tech workers today. Compared with last year, salaries inched up slowly, but with more employees seeing increases.

    Apr 7, 2014